Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by mmaltaison Aug 29, 2018 6:29pm

220 Views

Post# 28539061

Mcaquerie last month transaction.

Macquarie since last month. Hard to understand

Broker Positions for C:PLI Broker #11 from 20180730 to 20180829

Date	Bought	$Val	Ave	Sold	$Val	Ave	Net	Position	$Net	$Position
20180827	0			586,500	306,186	0.522	-586,500	-586,500	306,186	306,186
20180829	720,660	454,204	0.63	0			720,660	134,160	-454,204	-148,018
TOTAL	720,660	454,204	0.63	586,500	306,186	0.522		134,160		-148,018